Trials / Not Yet Recruiting
Not Yet RecruitingNCT07270432
Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia
Randomized Clinical Trial to Evaluate the Safety and Efficacy of Product DNN.65.21.005 in Alleviating Lower Urinary Tract Symptoms in Patients With Benign Prostatic Hyperplasia
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 218 (estimated)
- Sponsor
- Ache Laboratorios Farmaceuticos S.A. · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of DNN.65.21.005 versus Combodart® in the treatment of benign prostatic hyperplasia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Product DNN.65.21.005 | One capsule every 24 hours |
| DRUG | Combodart® | One capsule every 24 hours |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2025-12-08
- Last updated
- 2025-12-08
Source: ClinicalTrials.gov record NCT07270432. Inclusion in this directory is not an endorsement.